Orthofix International reported $-126M in Net Income for its fiscal quarter ending in December of 2024.





Net Income Change Date
AngioDynamics USD -4.41M 6.33M Feb/2025
AtriCure USD -267K 5.92M Sep/2025
Dexcom USD 179.8M 74.4M Jun/2025
EDAP TMS EUR -5.6M 1.47M Jun/2025
Globus Medical USD 118.97M 83.88M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 87.6M 65.1M Sep/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
J&J USD 5.12B 36M Dec/2025
Medtronic USD 1.37B 334M Sep/2025
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -126M 98.61M Dec/2024
Smith & Nephew USD 293M 79M Dec/2025
STAAR Surgical USD 8.88M 25.7M Sep/2025
Stryker USD 849M 10M Dec/2025
Surmodics USD -11.54M 3.99M Sep/2024
Tandem Diabetes Care USD -21.16M 31.24M Sep/2025
Teleflex USD -408.89M 531.47M Sep/2025
Veracyte USD 19.14M 20.12M Sep/2025
Zimmer Biomet Holdings USD 139.3M 91.6M Dec/2025